Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Tomas, Cieza"'
Role of Antitroponin Antibodies and Macrotroponin in the Clinical Interpretation of Cardiac Troponin
Autor:
Erwan Salaun, Samuel Drory, Marc‐André Coté, Veronic Tremblay, Elisabeth Bédard, Christian Steinberg, David Paré, Kim O'Connor, Tomas Cieza, Nancy Coté, Paul Poirier, Pierre Douville, Jonatan Blais, Philippe Desmeules, Dimitris Kalavrouziotis, Siamak Mohammadi, Pierre Voisine, Mathieu Bernier, Philippe Pibarot, Sébastien Thériault
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 12 (2024)
Cardiac troponin is extensively used as a biomarker in modern medicine due to its diagnostic capability for myocardial injury, as well as its predictive and prognostic value for cardiac diseases. However, heterophile antibodies, antitroponin antibodi
Externí odkaz:
https://doaj.org/article/906c4f5612b145fd94fa43d346867346
Publikováno v:
CJC Open, Vol 2, Iss 5, Pp 426-428 (2020)
Spontaneous coronary artery dissection (SCAD) is a cause of myocardial infarction with nonobstructive coronary arteries. We describe a case of SCAD in a 39-year-old postpartum woman who presented with acute anterior myocardial infarction, no coronary
Externí odkaz:
https://doaj.org/article/651aa0cd78a54fa4bfb7d8afe100f047
Autor:
James K. Chow, Akshay Bagai, Mary K. Tan, Bryan J. Har, Amelia M.C. Yip, Mario Paniagua, Basem Elbarouni, Kevin R. Bainey, Jean-Michel Paradis, Robert Maranda, Warren J. Cantor, Mark J. Eisenberg, Jean-Pierre Dery, Mina Madan, Tomas Cieza, Alexis Matteau, Sherryn Roth, Shahar Lavi, Anthony Glanz, Dongsheng Gao, Ravi Tahiliani, Robert C. Welsh, Hahn Hoe Kim, Simon D. Robinson, Benoit Daneault, Aun-Yeong Chong, Michel R. Le May, Vineeta Ahooja, Jean C. Gregoire, Pierre-Louis Nadeau, Zachary Laksman, Brett Heilbron, Derek Yung, Kunal Minhas, Ronald Bourgeois, Christopher B. Overgaard, Hamid Bonakdar, Giridhar Logsetty, Andrea J. Lavoie, Robert De LaRochelliere, Samer Mansour, Caroline Spindler, Andrew T. Yan, Shaun G. Goodman
Publikováno v:
Journal of Cardiology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ee0b0620480a9a45276917b9d3b6b28
https://doi.org/10.1016/j.jjcc.2023.03.004
https://doi.org/10.1016/j.jjcc.2023.03.004
Autor:
Carol Anne Graham, Mary K. Tan, Derek P. Chew, Christopher P. Gale, Keith A. A. Fox, Akshay Bagai, Mark A. Henderson, Ata ur Rehman Quraishi, Jean-Pierre Déry, Asim N. Cheema, Harold Fisher, David Brieger, Sohrab R. Lutchmedial, Shahar Lavi, Brian Y. L. Wong, Tomas Cieza, Shamir R. Mehta, Neil Brass, Shaun G. Goodman, Andrew T. Yan
Publikováno v:
Heart and Vessels. 37:1291-1298
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72ad544e11eb651b12ec6d9867c5490a
https://doi.org/10.1007/s00380-022-02029-8
https://doi.org/10.1007/s00380-022-02029-8
Autor:
Akshay Bagai, Shaun G. Goodman, Hahn Hoe Kim, Andrew T. Yan, Andrea Lavoie, Christopher B. Fordyce, Ashish Patel, Nathan W. Brunner, Tara Sedlak, Sean Jedrzkiewicz, Saleem Kassam, Roger K. Philipp, Sohrab Lutchmedial, Shahar Lavi, Mina Madan, Thao Huynh, Sam Radhakrishnan, Michael Heffernan, Andrew L Mathew, Mary Tan, Jean-Pierre Déry, Payam Dehghani, Robert McKelvie, Neville Suskin, Colin Barry, Tomas Cieza, Razi Khan, Shaheeda Ahmed
Publikováno v:
Clinical Cardiology. 44:839-847
BACKGROUND After myocardial infarction, guidelines recommend higher-potency P2Y12 receptor inhibitors, namely ticagrelor and prasugrel, over clopidogrel. HYPOTHESIS We aimed to determine the contemporary use of higher-potency antiplatelet therapy in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77ac8ee0137767bbe7b0c5f161b437e8
https://doi.org/10.1002/clc.23618
https://doi.org/10.1002/clc.23618
Autor:
Frédéric Maes, Tomas Cieza, Olivier F. Bertrand, Charles Pirlet, Marie-Eve Piché, Zoltán Ruzsa, Laurent Biertho, Paul Poirier
Publikováno v:
American journal of cardiovascular drugs, Vol. 21, no.3, p. 271-281 (2021)
Obesity is associated with the development and progression of multiple cardiovascular risk factors, such as hypertension, dyslipidemia, and type 2 diabetes mellitus, and is an important contributor to the global burden of atherosclerotic cardiovascul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6042f3af45f6d9ccb84b3d62464d9ab5
https://doi.org/10.1007/s40256-020-00428-8
https://doi.org/10.1007/s40256-020-00428-8
Autor:
Paul Poirier, Laurent Biertho, Tomas Cieza, Pierre Voisine, Charles Pirlet, Frédéric-Simon Hould, Zoltán Ruzsa, Olivier F. Bertrand, Rodrigo Bagur, François Julien
Publikováno v:
Obesity Surgery. 30:2085-2092
The clinical benefit of bariatric surgery in patients with severe obesity and established coronary artery disease (CAD) is unclear. We aimed to compare the cardiovascular outcomes of severely obese CAD patients with and without bariatric surgery. Pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b06657af56884c7b9b41e2dbb2b6dbc
https://doi.org/10.1007/s11695-020-04467-7
https://doi.org/10.1007/s11695-020-04467-7
Publikováno v:
Cardiovascular Revascularization Medicine. 21:222-226
Background/purpose Bariatric embolization of the left gastric artery (LGA) is being investigated as a technique to induce substantial weight loss in obese patients. Radial access is associated with less vascular complications than femoral access, esp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::427320eb563221e29cb8172c3e2ed28b
https://doi.org/10.1016/j.carrev.2019.04.012
https://doi.org/10.1016/j.carrev.2019.04.012
Autor:
Carol Anne, Graham, Mary K, Tan, Derek P, Chew, Christopher P, Gale, Keith A A, Fox, Akshay, Bagai, Mark A, Henderson, Ata Ur Rehman, Quraishi, Jean-Pierre, Déry, Asim N, Cheema, Harold, Fisher, David, Brieger, Sohrab R, Lutchmedial, Shahar, Lavi, Brian Y L, Wong, Tomas, Cieza, Shamir R, Mehta, Neil, Brass, Shaun G, Goodman, Andrew T, Yan
Publikováno v:
Heart and vessels. 37(8)
Chronic kidney disease (CKD) increases the risk of adverse outcomes in acute coronary syndrome (ACS). The optimal regimen of dual antiplatelet therapy (DAPT) post-percutaneous coronary intervention (PCI) in CKD poses a challenge due to the increased
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bd2e0e73e4f3f4767fda21a488823d02
https://pubmed.ncbi.nlm.nih.gov/35089380
https://pubmed.ncbi.nlm.nih.gov/35089380
Autor:
Sanam Verma, William Keeble, Rajendra M Chetty, Wayne J. Tymchak, David Laflamme, Michael C Hartleib, Tomas Cieza, Andy S. Lam, Dinkar Shukla, Randi C Rose, Christian Constance, Grace L Chua, Bruce J Lubelsky, Brian J. Potter, Razi Khan, Robert C. Welsh, Richard Choi, Kevin R. Bainey, Samer Mansour, Jean-Pierre Déry, Benoit Daneault, Shaun G. Goodman, Mary K. Tan
Publikováno v:
International Journal of Clinical Practice. 75
BACKGROUND Although acetylsalicylic acid is the most commonly used antithrombotic agent for the secondary prevention of cardiovascular events, residual atherothrombotic risk has prompted a guideline recommendation for the addition of dual antiplatele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84f86ae9604b90623ac6d345e39a6b42
https://doi.org/10.1111/ijcp.14597
https://doi.org/10.1111/ijcp.14597